Overview

Bioequivalence Study of Letrozole 2.5 mg Tablets

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Bioequivalence
Phase:
N/A
Details
Lead Sponsor:
Yuhan Corporation
Treatments:
Letrozole